Influence of <i>ABCB1</i> <i>3435C>T</i> polymorphism on methotrexate safety in patients with psoriasis
Background. Methotrexate is a highly effective systemic treatment for moderate to severe psoriasis, but drug toxicity may limit its use. Recent evidence suggests that it is necessary to take into account the individual characteristics of methotrexate pharmacokinetics, which are determined by the pre...
Main Authors: | Alexey A. Kubanov, Anastasiia V. Asoskova, Michael S. Zastrozhin, Zhannet A. Sozaeva, Dmitry A. Sychev |
---|---|
Format: | Article |
Language: | English |
Published: |
State Scientific Center of Dermatovenereology and Cosmetology
2023-02-01
|
Series: | Vestnik Dermatologii i Venerologii |
Subjects: | |
Online Access: | https://vestnikdv.ru/jour/article/viewFile/1321/pdf |
Similar Items
-
<i>ABCC1</i>, <i>ABCG2</i> and <i>FOXP3</i>: Predictive Biomarkers of Toxicity from Methotrexate Treatment in Patients Diagnosed with Moderate-to-Severe Psoriasis
by: Cristina Membrive-Jiménez, et al.
Published: (2023-09-01) -
Polymorphism in Gene for ABCC2 Transporter Predicts Methotrexate Drug Survival in Patients with Psoriasis
by: Jasna Grželj, et al.
Published: (2021-10-01) -
Occurrence of adverse events associated with the initiation of methotrexate and biologics for the treatment of psoriasis in routine clinical practice
by: Faizan Mazhar, et al.
Published: (2023-12-01) -
The Effect of Methotrexate 1% Topical Gel on Psoriasis
by: Gita Faghihi, et al.
Published: (2012-03-01) -
Side Effects of Methotrexate for Psoriasis Therapy
by: Melida Agustina, et al.
Published: (2020-07-01)